DOW JONES21,068.84-848.32 -3.87%
S&P 5002,475.92-108.67 -4.20%
NASDAQ7,391.73-308.37 -4.00%

J&J's Janssen Announces FDA Breakthrough Therapy Designation Granted For JNJ-6372 For The Treatment Of Non-Small Cell Lung Cancer

-Reuters-Reuters

Reuters-Reuters · 03/10/2020 20:04